Company
Description
Rafael Biotechnology Co., Limited was founded in October 2018 by Dr. Siu pang NG in the Hong Kong, and established its subsidiary in Shenzhen in May 2025. The company focuses on Quantum Plasmonic Resonance Biochip (QPB) technology, specializing in the research, development, production, and sales of high-performance label-free biosensing instruments, supporting equipment, and cost-effective consumables. Our solutions serve scientific research, drug development, and in vitro diagnostics (IVD). Integrating materials science, nanotechnology, biochemistry, and quantum metrology, QPB sensors address the growing demand in emerging infectious disease molecular diagnostics, innovative drug development, and tumor companion diagnostics, delivering more accessible and highly sensitive detection solutions.
